1. Home
  2. BRIA vs ANIX Comparison

BRIA vs ANIX Comparison

Compare BRIA & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRIA
  • ANIX
  • Stock Information
  • Founded
  • BRIA 2011
  • ANIX 1982
  • Country
  • BRIA Singapore
  • ANIX United States
  • Employees
  • BRIA N/A
  • ANIX N/A
  • Industry
  • BRIA
  • ANIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRIA
  • ANIX Health Care
  • Exchange
  • BRIA NYSE
  • ANIX Nasdaq
  • Market Cap
  • BRIA 86.3M
  • ANIX 82.7M
  • IPO Year
  • BRIA 2024
  • ANIX 1987
  • Fundamental
  • Price
  • BRIA $3.32
  • ANIX $3.14
  • Analyst Decision
  • BRIA
  • ANIX Strong Buy
  • Analyst Count
  • BRIA 0
  • ANIX 2
  • Target Price
  • BRIA N/A
  • ANIX $8.50
  • AVG Volume (30 Days)
  • BRIA 16.1K
  • ANIX 128.9K
  • Earning Date
  • BRIA 02-24-2025
  • ANIX 03-11-2025
  • Dividend Yield
  • BRIA N/A
  • ANIX N/A
  • EPS Growth
  • BRIA N/A
  • ANIX N/A
  • EPS
  • BRIA 92.24
  • ANIX N/A
  • Revenue
  • BRIA $55,755,669.00
  • ANIX N/A
  • Revenue This Year
  • BRIA N/A
  • ANIX N/A
  • Revenue Next Year
  • BRIA N/A
  • ANIX N/A
  • P/E Ratio
  • BRIA $0.04
  • ANIX N/A
  • Revenue Growth
  • BRIA 8.03
  • ANIX N/A
  • 52 Week Low
  • BRIA $2.90
  • ANIX $2.07
  • 52 Week High
  • BRIA $4.38
  • ANIX $4.20
  • Technical
  • Relative Strength Index (RSI)
  • BRIA N/A
  • ANIX 60.67
  • Support Level
  • BRIA N/A
  • ANIX $2.87
  • Resistance Level
  • BRIA N/A
  • ANIX $3.22
  • Average True Range (ATR)
  • BRIA 0.00
  • ANIX 0.18
  • MACD
  • BRIA 0.00
  • ANIX 0.02
  • Stochastic Oscillator
  • BRIA 0.00
  • ANIX 81.67

About BRIA BRILLIA INC

BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Share on Social Networks: